RJ-014

N/A

Report date: 2024/04/28 16:18:13

Base Information

Drug NameRJ-014
Drug Alias NameRJ014RJ-014
ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)
Mechanisms of ActionProteolysis
TargetsNot applicable
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesRisen (Suzhou) Pharma Tech Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesRisen (Suzhou) Pharma Tech Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A